Monday, 10 December 2018

Gilead Sciences snares Roche veteran O'Day as CEO

Drugmaker Gilead Sciences Inc on Monday named Roche Holding AG's Daniel O'Day as its new chief executive, tapping an industry veteran to fill a management vacuum.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)